Long‐Term Survival With Olaparib Maintenance Therapy in Metastatic Pancreatic Carcinoma of a Patient Harboring Germline BRIP1 and ATM Mutations. This evidence concerns the gene BRIP1 and exocrine pancreatic carcinoma.